| |
| |
|
| Insider
Information: |
Hearne Michael S |
| Relationship: |
Chief Financial Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,620 |
|
|
Indirect Shares
|
12,767,435 |
|
|
| Direct
Value |
$7,465,690 |
|
|
|
Indirect Value
|
$36,380,806,033 |
|
|
| Total
Shares |
12,770,055 |
|
|
| Total
Value |
$36,388,271,723 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
20
|
3
|
|
Stock
price went up :
|
10
|
0
|
| Stock
price went down : |
10
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -17.1%
|
-97.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Odonate Therapeutics Inc |
ODT |
Chief Financial Officer |
2021-03-15 |
2,620 |
2021-11-19 |
12,767,435 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Chief Financial Officer |
2022-08-22 |
0 |
2022-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-11-18 |
4 |
S |
$1.88 |
$2,081,879 |
I/I |
(1,094,265) |
13,132,724 |
0 |
% |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-11-19 |
4 |
S |
$1.92 |
$699,930 |
I/I |
(365,289) |
12,767,435 |
0 |
% |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-11-17 |
4 |
S |
$1.99 |
$2,948,748 |
I/I |
(1,287,577) |
14,226,989 |
0 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-06-30 |
4 |
A |
$2.71 |
$640 |
D/D |
236 |
10,186 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-06-15 |
4 |
A |
$2.72 |
$642 |
D/D |
236 |
9,950 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-10-30 |
4 |
A |
$2.89 |
$566 |
D/D |
196 |
365 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-07-30 |
4 |
A |
$3.07 |
$617 |
D/D |
201 |
4,646 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-05-14 |
4 |
A |
$3.20 |
$617 |
D/D |
193 |
3,765 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-07-15 |
4 |
A |
$3.20 |
$617 |
D/D |
193 |
4,445 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-12-31 |
4/A |
A |
$3.30 |
$5,435 |
D/D |
1,648 |
2,435 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-12-31 |
4 |
A |
$3.30 |
$564 |
D/D |
171 |
958 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-10-15 |
4 |
A |
$3.32 |
$561 |
D/D |
169 |
169 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-10-15 |
4 |
A |
$3.37 |
$616 |
D/D |
183 |
5,557 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-03-15 |
4 |
A |
$3.37 |
$640 |
D/D |
190 |
8,802 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-09-15 |
4 |
A |
$3.39 |
$1,852 |
D/D |
546 |
5,192 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-09-30 |
4 |
A |
$3.39 |
$617 |
D/D |
182 |
5,374 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-11-15 |
4 |
A |
$3.41 |
$617 |
D/D |
181 |
5,919 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-05-13 |
4 |
A |
$3.41 |
$641 |
D/D |
188 |
9,525 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-05-31 |
4 |
A |
$3.41 |
$644 |
D/D |
189 |
9,714 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-10-29 |
4 |
A |
$3.42 |
$618 |
D/D |
181 |
5,738 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-08-12 |
4 |
B |
$3.47 |
$150,820 |
I/I |
43,513 |
8,738,987 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-04-29 |
4 |
A |
$3.47 |
$642 |
D/D |
185 |
9,337 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-02-28 |
4 |
A |
$3.48 |
$643 |
D/D |
185 |
8,612 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-04-15 |
4 |
A |
$3.55 |
$615 |
D/D |
173 |
3,835 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-12-15 |
4 |
A |
$3.58 |
$619 |
D/D |
173 |
6,278 |
0 |
- |
|
145 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
